Literature DB >> 3475509

Estradiol metabolism in Ishikawa endometrial cancer cells.

H Hata, C F Holinka, S L Pahuja, R B Hochberg, H Kuramoto, E Gurpide.   

Abstract

Estrogen-responsive human cells derived from a specimen of well differentiated endometrial adenocarcinoma (Ishikawa line) were incubated with [3H]estradiol (E2) at various concentrations and the medium was sampled at 3, 6 and 24 h to evaluate the kinetics of removal of the hormone and the formation of unconjugated or sulfated metabolites. The detectable products of metabolism were estrone and the conjugate estradiol-3-sulfate. The latter was identified by high pressure chromatography, before and after acetylation, oxidation, and hydrolysis. The disappearance of [3H]E2 from the medium was found to follow first order kinetics between 3 and 24 h, with half-lives increasing from 4.7 to 53 h as the initial concentrations of the hormone were raised from 10(-8) to 10(-6)M. At the lowest concentration, practically all of the [3H]E2 added to the cultures was converted to estradiol-3-sulfate in 24 h, whereas at 10(-6)M oxidation to estrone was quantitatively more important than sulfation. These results indicate the presence in Ishikawa cells of an estrogen sulfotransferase of low Michaelis constant for E2, and 17 beta-oxidoreductase activity that significantly contributes to the metabolism of E2 only at higher concentrations of substrate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475509     DOI: 10.1016/0022-4731(87)91042-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  6 in total

1.  Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.

Authors:  Emily Berry; Jennifer L Hardt; Jon Clardy; John R Lurain; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-11-28       Impact factor: 5.482

Review 2.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

3.  Androgens Upregulate Endometrial Epithelial Progesterone Receptor Expression: Potential Implications for Endometriosis.

Authors:  Samir N Babayev; Chan Woo Park; Patrick W Keller; Bruce R Carr; Ruth A Word; Orhan Bukulmez
Journal:  Reprod Sci       Date:  2017-02-12       Impact factor: 3.060

4.  DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.

Authors:  Birgit M Dietz; Shao-Nong Chen; René F Ramos Alvarenga; Huali Dong; Dejan Nikolić; Martin Biendl; Richard B van Breemen; Judy L Bolton; Guido F Pauli
Journal:  J Nat Prod       Date:  2017-08-16       Impact factor: 4.050

5.  Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs.

Authors:  Heba E Elnakib; Marian M Ramsis; Nouran O Albably; Merna A Vector; Jan J Weigand; Kai Schwedtmann; Jannette Wober; Oliver Zierau; Günter Vollmer; Ashraf H Abadi; Nermin S Ahmed
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

6.  Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms.

Authors:  Atieh Hajirahimkhan; Charlotte Simmler; Yang Yuan; Jeffrey R Anderson; Shao-Nong Chen; Dejan Nikolić; Birgit M Dietz; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.